Home LiteratureArticle Details
PMID: 4043568 Published · ppublish English Journal Article

Toxic products in hemorrhagic ascitic fluid generated during experimental acute hemorrhagic pancreatitis in dogs and a treatment which reduces their effect.

Digestion ·Vol. 32 ·No. 2 ·1985-00-00 ·Pages 99-105

Satake K, Koh I, Nishiwaki H, Umeyama K

Abstract

Toxic substances produced in hemorrhagic ascitic fluid during experimental hemorrhagic pancreatitis in dogs were investigated. An average of 394 ml of ascitic fluid was produced within 5 h after the induction of acute pancreatitis by intraductal injection of a mixture of autologous bile and trypsin. Hemorrhagic ascitic fluid was collected under sterile conditions, which was confirmed by aerobic and anaerobic culture and a Limulus test. The sterile fluid was injected intraperitoneally into mice in doses of 2 and 3 ml, and the mortality rate 72 h after injection was 66.0 and 88.4%, respectively. It contained high concentrations of pancreatic enzymes, including trypsin and esterase activity, as well as bradykinin, histamine and prostaglandin. Autopsy and histological examination of mice revealed shock with lung damage. The results suggest that hemorrhagic ascitic fluid produced in pancreatitis may be an important factor for early deaths in acute pancreatitis. When a new synthetic antiprotease (nafamstat mesilate) in a dosage of 0.2 mg was mixed with 1 ml of ascitic fluid, trypsin was not detectable, and bradykinin was reduced 1.0 ng/ml from 8.0 ng/ml, while esterase activity decreased to one tenth of its previous activity. The mortality following injection of the solution decreased to 26.7 and 80.6%, respectively. These results indicate that peritoneal lavage with a solution containing antiprotease may be an effective treatment for hemorrhagic acute pancreatitis.

MeSH Terms
Acute Disease Animals Ascitic Fluid/complications,metabolism Benzamidines Disease Models, Animal Dogs Female Guanidines/therapeutic use Hemorrhage/drug therapy,metabolism Male Mice Pancreatitis/drug therapy,metabolism Protease Inhibitors/therapeutic use
Chemicals
Benzamidines Guanidines Protease Inhibitors nafamostat
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Satake K
Koh I
Nishiwaki H
Umeyama K
Article Info
Journal
Digestion
Abbr.
Digestion
ISSN
0012-2823
Published
1985-00-00
Pages
99-105
Language
English
Region
Switzerland
NLM ID
0150472
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]